Articles by Disease (Mesothelioma)

Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease

Journal: Current Pharmaceutical Biotechnology
Volume: 4
Page: 21-37
Author(s): C. Ivorra, H. Samyn, M. D. Edo, C. Castro, S. M. Sanz-González, A. Diez-Juan and V. Andres

Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application

Journal: Current Gene Therapy
Volume: 3
Page: 13-26
Author(s): C. Fillat, M. Carrio, A. Cascante and B. Sangro

Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress

Journal: Current Cancer Drug Targets
Volume: 2
Page: 337-353
Author(s): B. G. Gabrielli, R. W. Johnstone and N. A. Saunders

Gene Therapy Approaches for the Selective Killing of Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1683-1694
Author(s): Eva Maria Westphal and Harald von Melchner

Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.

Journal: Current Gene Therapy
Volume: 2
Page: 307-322
Author(s): Ingrid J. van Dillen, Nanno H. Mulder, Willem Vaalburg, Erik F.J. de Vries and Geke A.P. Hospers

The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 589-603
Author(s): L. A. Beltz

The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger

Journal: Current Drug Targets
Volume: 3
Page: 297-309
Author(s): Randal W. Berg, Peter J. Ferguson, Janice M. DeMoor, Mark D. Vincent and James Koropatnick